Unknown

Dataset Information

0

Crystal structure of plant PLD?1 reveals catalytic and regulatory mechanisms of eukaryotic phospholipase D.


ABSTRACT: Phospholipase D (PLD) hydrolyzes the phosphodiester bond of glycerophospholipids and produces phosphatidic acid (PA), which acts as a second messenger in many living organisms. A large number of PLDs have been identified in eukaryotes, and are viewed as promising targets for drug design because these enzymes are known to be tightly regulated and to function in the pathophysiology of many human diseases. However, the underlying molecular mechanisms of catalysis and regulation of eukaryotic PLD remain elusive. Here, we determined the crystal structure of full-length plant PLD?1 in the apo state and in complex with PA. The structure shows that the N-terminal C2 domain hydrophobically interacts with the C-terminal catalytic domain that features two HKD motifs. Our analysis reveals the catalytic site, substrate-binding mechanism, and a new Ca2+-binding site that is required for the activation of PLD. In addition, we tested several efficient small-molecule inhibitors against PLD?1, and suggested a possible competitive inhibition mechanism according to structure-based docking analysis. This study explains many long-standing questions about PLDs and provides structural insights into PLD-targeted inhibitor/drug design.

SUBMITTER: Li J 

PROVIDER: S-EPMC6951347 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Crystal structure of plant PLDα1 reveals catalytic and regulatory mechanisms of eukaryotic phospholipase D.

Li Jianxu J   Yu Fang F   Guo Hui H   Xiong Renxue R   Zhang Wenjing W   He Fangyuan F   Zhang Minhua M   Zhang Peng P  

Cell research 20191016 1


Phospholipase D (PLD) hydrolyzes the phosphodiester bond of glycerophospholipids and produces phosphatidic acid (PA), which acts as a second messenger in many living organisms. A large number of PLDs have been identified in eukaryotes, and are viewed as promising targets for drug design because these enzymes are known to be tightly regulated and to function in the pathophysiology of many human diseases. However, the underlying molecular mechanisms of catalysis and regulation of eukaryotic PLD re  ...[more]

Similar Datasets

| S-EPMC8004604 | biostudies-literature
| S-EPMC2576301 | biostudies-literature
| S-EPMC6697444 | biostudies-literature
| S-EPMC3970898 | biostudies-literature
| S-EPMC2913127 | biostudies-literature
| S-EPMC6881789 | biostudies-literature
| S-EPMC6255198 | biostudies-literature
| S-EPMC3160183 | biostudies-literature
| S-EPMC7427993 | biostudies-literature
| S-EPMC10182977 | biostudies-literature